Four out of 10 eczema patients struggle with sleep, and they may not volunteer that information unless you ask.

The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...

Rising demand for minimally invasive procedures, preventive aesthetics, and novel therapeutic uses position botulinum toxins ...

Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ...

AbbVie announced a significant expansion at its North Chicago facility, with plans to enhance U.S. production capacities for ...

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), an autologous stem cell company developing and commercializing ...

In July 2025, AbbVie announced a Phase 1/2 Study to Evaluate the Safety and Efficacy of AGN-193408 SR in Participants With ...

Xilio anticipates nominating development candidates for its PSMA program (ATACR format), CLDN18.2 program (ATACR format) and STEAP1 program (SEECR format) in the third quarter of 2025, fourth quarter ...

Nexgel, Inc. (($NXGL)) has held its Q2 earnings call. Read on for the main highlights of the call. NEXGEL, Inc. recently held its earnings call, ...

AbbVie will invest $195 million in its North Chicago, Illinois, manufacturing plant to expand domestic API production in the ...

In Westport, an Irish town transformed by a pharmaceutical plant that manufactures the world’s Botox, there are fears ...

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Abbott Laboratories spinoff AbbVie will ...